INSIGHTS ON CLINICAL TRIAL DESIGN

• 4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials

  Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

• Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates

  Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.

• Advancing Clinical Research In 2025: Meeting FDA Standards In DCT

  Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.

• Rewriting Cancer: Advancing Patient Access, Together

  Rewriting Cancer puts a spotlight on the push to connect more patients to clinical trials and how data, technology, and lived experience can help expand access to life-changing care.

• Phase 1 Trial In Painful Diabetic Peripheral Neuropathy

  2/24/2026

  A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.

• GA Screening: Early Detection For Future Trial Recruitment

  4/9/2026

  Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.

• Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays

  9/25/2025

  Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

• Continuous Passive Monitoring's Effect On Sleep Disorder Research

  3/16/2026

  Bridge the gap between clinical sleep studies and real-world behavior. Use continuous, wearable-enabled data to objectively measure daytime sleepiness and improve sleep disorder research.

• Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements

  2/9/2026

  In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).